首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Solid-phase microextraction coupled to gas chromatography–mass spectrometry followed by multivariate data analysis for the identification of volatile organic compounds as possible biomarkers in lung cancer tissues
【24h】

Solid-phase microextraction coupled to gas chromatography–mass spectrometry followed by multivariate data analysis for the identification of volatile organic compounds as possible biomarkers in lung cancer tissues

机译:与气相色谱 - 质谱相结合的固相微萃取,然后通过多变量数据分析,以在肺癌组织中鉴定挥发性有机化合物的挥发性有机化合物

获取原文
获取原文并翻译 | 示例
       

摘要

Graphical abstract Display Omitted Highlights ? SPME–GC–MS as valuable tool for the identification of lung cancer biomarkers. ? Use of multivariate data analysis for discriminating healthy and carcinogenic tissues. ? Seven potential lung cancer biomarkers were identified. ? Correct classification of more than 98% of the samples. Abstract Solid-phase microextraction and gas chromatography–mass spectrometry followed by multivariate data analysis were used to analyze lung tissues from both healthy and carcinogenic patients. A total of 78 volatile compounds belonging to different chemical classes were identified, seven of which were able to discriminate between the two groups. Discriminant analysis allowed to correctly classify 98.3% of the cases. By using the leave-one-method, 100% of the cross-validated samples belonging to the “tumor” group was correctly classified, whereas 2 cross-validated healthy samples out of 48 were erroneously allocated in the “tumor” group. Achieved results suggest the need of further investigation to assess the role of the seven identified compounds as lung cancer biomarkers in breath analysis, thus allowing the development of low-cost diagnostic devices.
机译:图形抽象显示省略了亮点? SPME-GC-MS作为鉴定肺癌生物标志物的宝贵工具。还是多变量数据分析辨别健康和致癌组织的用途。还是鉴定了七种潜在的肺癌生物标志物。还是正确分类超过98%的样品。摘要采用多元微萃取和气相色谱 - 质谱,随后进行多元数据分析,用于分析健康和致癌患者的肺组织。确定了属于不同化学类别的78种挥发性化合物,其中7种能够区分两组。判别分析允许正确分类98.3%的病例。通过使用休假 - 单方法,100%属于“肿瘤”组的交叉验证样本被正确分类,而在“肿瘤”组中错误地分配48个交叉验证的健康样品。达到的结果表明需要进一步调查,以评估七种已鉴定的化合物作为肺癌生物标志物的作用,从而允许开发低成本的诊断装置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号